These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36447079)

  • 1. The diagnostic experience of women with fragile X-associated primary ovarian insufficiency (FXPOI).
    Poteet B; Ali N; Bellcross C; Sherman SL; Espinel W; Hipp H; Allen EG
    J Assist Reprod Genet; 2023 Jan; 40(1):179-190. PubMed ID: 36447079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.
    Utine GE; Şimşek-Kiper PÖ; Akgün-Doğan Ö; Ürel-Demir G; Alanay Y; Aktaş D; Boduroğlu K; Tunçbilek E; Alikaşifoğlu M
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():76-80. PubMed ID: 29275276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding decreased fertility in women carriers of the FMR1 premutation: a possible mechanism for Fragile X-Associated Primary Ovarian Insufficiency (FXPOI).
    Peprah E
    Reprod Health; 2014 Aug; 11():67. PubMed ID: 25134882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FMR1 and the continuum of primary ovarian insufficiency.
    Sullivan SD; Welt C; Sherman S
    Semin Reprod Med; 2011 Jul; 29(4):299-307. PubMed ID: 21969264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.
    Albizua I; Rambo-Martin BL; Allen EG; He W; Amin AS; Sherman SL
    Am J Med Genet A; 2017 Nov; 173(11):2985-2994. PubMed ID: 28941155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining the risk for fragile X-associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size.
    Allen EG; Charen K; Hipp HS; Shubeck L; Amin A; He W; Nolin SL; Glicksman A; Tortora N; McKinnon B; Shelly KE; Sherman SL
    Genet Med; 2021 Sep; 23(9):1648-1655. PubMed ID: 33927378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.
    Hoyos LR; Thakur M
    J Assist Reprod Genet; 2017 Mar; 34(3):315-323. PubMed ID: 27995424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.
    Hunter JE; Epstein MP; Tinker SW; Charen KH; Sherman SL
    Genet Epidemiol; 2008 Sep; 32(6):553-9. PubMed ID: 18357616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of key signaling pathways involved in oocyte maturation in FMR1 premutation carriers with Fragile X-associated primary ovarian insufficiency.
    Alvarez-Mora MI; Rodriguez-Revenga L; Madrigal I; Garcia-Garcia F; Duran M; Dopazo J; Estivill X; Milà M
    Gene; 2015 Oct; 571(1):52-7. PubMed ID: 26095811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.
    Lu C; Lin L; Tan H; Wu H; Sherman SL; Gao F; Jin P; Chen D
    Hum Mol Genet; 2012 Dec; 21(23):5039-47. PubMed ID: 22914733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions.
    Mailick MR; Hong J; Greenberg J; Smith L; Sherman S
    Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):705-11. PubMed ID: 25346430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency.
    Rosario R; Stewart HL; Choudhury NR; Michlewski G; Charlet-Berguerand N; Anderson RA
    FASEB J; 2022 Nov; 36(11):e22612. PubMed ID: 36250920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI).
    Hipp HS; Charen KH; Spencer JB; Allen EG; Sherman SL
    Menopause; 2016 Sep; 23(9):993-9. PubMed ID: 27552334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FMRpolyG accumulates in FMR1 premutation granulosa cells.
    Friedman-Gohas M; Elizur SE; Dratviman-Storobinsky O; Aizer A; Haas J; Raanani H; Orvieto R; Cohen Y
    J Ovarian Res; 2020 Feb; 13(1):22. PubMed ID: 32101156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian reserve in patients with FMR1 gene premutation and the role of fertility preservation.
    Le Poulennec T; Dubreuil S; Grynberg M; Chabbert-Buffet N; Sermondade N; Fourati S; Siffroi JP; Héron D; Bachelot A
    Ann Endocrinol (Paris); 2024 Jul; 85(4):269-275. PubMed ID: 38702011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family].
    González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ
    Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.
    De Caro JJ; Dominguez C; Sherman SL
    Ann N Y Acad Sci; 2008; 1135():99-111. PubMed ID: 18574214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An explanation of the mechanisms underlying fragile X-associated premature ovarian insufficiency.
    Rose BI; Brown SE
    J Assist Reprod Genet; 2020 Jun; 37(6):1313-1322. PubMed ID: 32377997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.